Assoc. Prof. Tanyaluck Thientunyakit, M.D.

Division : Nuclear Medicine, Department of Radiology

Specialty groups : Nuclear Medicine Imaging, Radionuclide therapy

Languages : Thai, English

Field of interests : Nuclear Medicine and Molecular imaging, Radionuclide therapy, Quality and safety management in Radiology, Routine to Research, Neuroimaging

Education
Year
2010
Fellowship in PET (IAEA), Austin Health, Melbourne, Australia
2004
Nuclear Medicine, Chulalongkorn University, Faculty of Medicine, Bangkok, Thailand
2002
Diploma in Clinical Sciences in Radiology, Chulalongkorn University, Faculty of Medicine, Bangkok, Thailand
2001
Internship, Prince of Songkla University (Internship), Hat Yai, Thailand
2000
M.D. Khon Kaen University, Faculty of Medicine (Medicine), Khon Kaen, Thailand
Certifications
Year
2019
IAEA regional workshop on Nuclear Medicine Applications (SPECT and PET) in the Diagnosis of Neurological conditions
2018
IAEA National Training Course in SPM
2017
IAEA National Training Course in Nuclear Neurology
2017
CITI program: Information Privacy Security, Biomedical Responsible Conduct of Research, Human Subject Research - Biomedical Researchers
2017
Fellow of Asian Nuclear Medicine Board
2017
IAEA Workshop on Nuclear Medicine Techniques in Theragnostics and Dementias
2016
IAEA Workshop: Nuclear Medicine Techniques in Neurological Diseases: Emphasis on Oncology and Neurology (ICNMP-PA) – Part I
2016
IAEA/RCA Regional Training Course on the Principles and Practice of the use of Radiopharmaceuticals for the Treatment of Lymphoma and other Malignancies
2015
IAEA/RCA Regional Training Course on Nuclear Medicine Techniques Thyroid cancer, Bone Pain Palliation and Peptide Receptor Radioisotope Therapy for Neuro Endocrine Tumors
2014
United Nations: Department of Safety and Security, Basic Security in the field II and Advanced Security in the Field
2013
IAEA/RCA Regional Training Course on Multimodality Approaches in the Diagnosis of Cardiovascular Diseases
2010
IAEA/RCA Regional Training Course on Reporting in Advanced Clinical Applications of Positron Emission Tomography (PET)
2010
Certificate of fellowship in PET, Austin Health, Melbourne, Australia
2004
Thai Board of Nuclear Medicine, Medical Coucil, Thailand
Awards and honors
Year
2020
Siriraj Award of Honor
2020
Board of Directors, Brain Imaging Council, Society of Nuclear Medicine
and Molecular Imaging
2019 - Present
National Ambassador to Thailand, European Society for Hybrid, Molecular and Translational Imaging
2020
International Best Abstract Award, SNMMI Annual Meeting, Anaheim, USA
2019
National R2R award: Tertiary level, National Health R2R Forum, Khon Kaen, Thailand
2019
Best international Abstract Award, SNMMI Annual Meeting, Anaheim, USA
2019
European Congress of Radiology 2019 Award, Vienna, Austria
2018
Emerging Leader award, World Federation of Nuclear Medicine and Biology, Melbourne, Australia
2017
Best poster presentation award in the Annual Meeting of Dementia Association of Thailand, Bangkok, Thailand
2017
RCARO Expert Support Program Award
2016
IAEA Research Presentation Award, IMIC 2016
2016
Lean R2R award, Faculty of Medicine Siriraj Hospital, Thailand
2015
IAEA Research Presentation Award, IPET 2015
2014
Lean R2R award, Faculty of Medicine Siriraj Hospital, Thailand
2012
Lean R2R award, Faculty of Medicine Siriraj Hospital, Thailand
2012
National Routine to Research award, Annual Meeting of National HA Forum, Bangkok, Thailand
Professional memberships
Year
2020 - Present
Member, Thai Young Scientist Academy
2019 – Present
Corresponding member, European Society of Hybrid Imaging
2018 – Present
Member, Dementia Association of Thailand
2018 – Present
Member, Radiological Society of Thailand (RST)
2018 - Present
Member, Brain Imaging Council, Society of Nuclear Medicine and Molecular Imaging
2018 - Present
Member, Society of Nuclear Medicine and Molecular Imaging
2018 - Present
Associate member, European Society of Radiology (ESR)
2018 - Present
Committee, Collaborative Aging and Dementia Research Society Thailand
2015 - Present
Member, World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)
2014 - Present
Member, Nuclear Medicine Society of Thailand and Royal College of  Radiologist (RCRT), Thailand
Professional organization
Year
2020 - present
Co-Leaders for Scinetific Communication Pillar, Thai Young Scientists Academy
2020 – present
Board of Directors, Brain Imaging Council, Society of Nuclear Medicine
and Molecular Imaging
2019 – present
National Ambassador of Thailand, European Society of Hybrid Imaging
2018 – present
Committee, Collaborative Aging and Dementia Research Society Thailand
Recent publications
Journal
  1. Thientunyakit T, Mail, Thiravit P , Mali P , Kanchanapiboon P. Benefit of Contrast-Enhanced PET/CT versus Non-Contrast-Enhanced PET/CT Relative to Lesion Detection, Lesion Characterization, and Diagnostic Accuracy in Patients with Cancer. J Med Assoc Thai 2020; 103:904-13.
  2. Thientunyakit T, Minoshima S. Temporal muscle uptake causing an unusual focal artifact on 3D-SSP statistical maps of [18F]FDG brain PET in a patient with Alzheimer’s disease: A case report. World J Nucl Med. 2020;19:168–170.
  3. Thientunyakit T, Thongpraparn T, Siriprapa T, Gelovani JG. Head-to-head comparison of 18F-Fluorodeoxyglucose and 18F-Fluorocholine PET/CT in three patients with rare gestational trophoblastic neoplasms. World J Nucl Med. 2020;19:72-77.
  4. Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Vichianin Y, et al. Relationships Between Amyloid Levels, Glucose Metabolism, Morphologic Changes in the Brain and Clinical Status of Patients with Alzheimer’s Disease. Ann Nucl Med. 2020;34:337-348.
  5. Thientunyakit T, Sethanandha C, Muangpaisan W, Minoshima S. Relationship between amyloid deposition and cerebral glucose metabolism in cognitively normal elderly, patients with mild cognitive impairment and Alzheimer’s dementia. J Nucl Med. 2019 60:14582.
  6. Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, et al. A Novel Multi-Modality Molecular Imaging Index of Amyloid, Glucose Metabolism, and Morphologic Changes in the Brain for Evaluation of Patients with Dementia:A Thailand Perspective. J Nucl Med. 2019;60:1459
  7. Chawalparit O, Wontaneeporn N, Muangpaisan W, Thientunyakit T, Charnchaowanish P, Ngamsonbat C. MRI Hippocampal Subfield Volume Analysis: Comparison between Alzheimer’s Disease, Mild Cognitive Impairment, and Normal Aging Subjects in an Amyloid PET Project. J Alzheimers Dis Parkinsonism. 2019;9: 459.
  8. Wongngamrungroj A, Soongsathitanon S, Kanchanapiboon P, Thientunyakit T. Residual Radioactivity in Patients with Well-Differentiated Thyroid Cancer Receiving High Dose I-131 Therapy. J Med Assoc Thai. 2019; 102:1-8.
  9. Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, et al. Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer’s disease: first-hand experience in Thailand. Nucl Med Commun. 2018; 39:186–192.
  10. Thientunyakit T. F-18 FDG PET/CT scan helps in correct localization of primary esophageal cancer in a case of SCCA metastasis to the skull previously suspected from primary lung cancer. Siriraj Med J. 2017; 69:159-161.
  11. Thientunyakit T, Kaewput C, Ubolnuch K, Wangkawan T, Mali P. The Effect of a Shortened Fasting State Prior to Radiotracer Administration on Upper Abdominal Artifacts in Myocardial Perfusion Scan: A Pilot Study. Siriraj Med J. 2017; 69:268-275.
  12. Thientunyakit T, Wongsurawat N, Hannantawiwat C, Nimmanit A. Relationship Between Fasting Blood Glucose Level and 18F-FDG PET/CT Biodistribution Quality in Patients with Cancer: How much should we concern? J Med Assoc Thai. 2017; 100:578-587.
  13. Thientunyakit T, Thongpraparn T, Phongsawat N. Left Ventricular Ejection Fraction Analysis in an Equilibrium Cardiac Gated Blood Pool Study: Is the Same Software Package Really Needed to Follow Up the Same Patient? Siriraj Med J. 2015; 67; 173-180.
Book Chapter
  1. Tanyaluck Thientunyakit. Amyloid PET scan in preclinical dementia: Towards early diagnosis and prevention. In Medicine Update 2018 Vol.2. Bangkok: Faculty of Medicine Siriraj Hospital Mahidol University; 2018:149-162. ISBN 978-616-8201-01-5. (Thai)
  2. Tanyaluck Thientunyakit. Screening for Lung Cancer: Role of PET/CT. In Medicine Update 2017: Hand in Hand towards Healthy Society. Bangkok: Print and More; 2017: 5-12. ISBN 978-616-407-176-6. (Thai)
  3. Tanyaluck Thientunyakit. Radioiodine treatment in Well-Differentiated Thyroid Cancer. In Pornchai Ochareonrat, Seubwong Chutaphisit, Wisanu Lohsiriwat, eds. Head-Neck and Breast Surgery. Vol.7 : Update in Thyroid Diseases. Bangkok: Krungthep Vejsarn; 2013:310-333. ISBN 978-616-279-2137. (Thai)
  4. Tanyaluck Thientunyakit. Radioiodine treatment in Hyperthyroidism. In Pornchai Ochareonrat, Seubwong Chutaphisit, Wisanu Lohsiriwat, eds. Head-Neck and Breast Surgery. Vol.7 : Update in Thyroid Diseases. Bangkok: Krungthep Vejsarn; 2013:119-148. ISBN 978-616-279-2137. (Thai)
  5. Tanyaluck Thientunyakit. Screening for lung cancer. In: Rojana Sirisriro, Editor. Clinical application of PET Scan in Lung Cancer. Bangkok: Siam Thong Kij, Ltd,;2013:78-99. ISBN 978-616-305-2063. (Thai)
Abstract
  1. Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, et al. A Novel Multi-Modality Molecular Imaging Index of Amyloid, Glucose Metabolism, and Morphologic Changes in the Brain for Evaluation of Patients with Dementia: A Thailand Perspective. J Nucl Med. 2019; 60: suppl 1 1459.
  2. Thientunyakit T, Sethanandha C, Muangpaisan W, Minoshima S. Relationship between Amyloid Deposition and Cerebral Glucose Metabolism in Cognitively Normal Elderly, Patients with Mild Cognitive Impairment and Alzheimer’s Dementia. J Nucl Med. 2019; 60: suppl 1 1458.20